SEC-sourced researchBeta
RNAC
Cartesian Therapeutics, Inc.
Company comparison ↗
Data passport
- CIK
- 0001453687
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Sep 29, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 38,275,000.0000 | Mar 9, 2026 |
| December 2025 | 400,000.0000 | Mar 9, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 400,000.0000 | -130,302,000.0000 | -73,941,000.0000 | 296,411,000.0000 | 422,651,000.0000 | Mar 9, 2026 |
| December 2024 | 38,275,000.0000 | -77,424,000.0000 | -23,674,000.0000 | 435,023,000.0000 | 441,825,000.0000 | Mar 9, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $400K | December 2025 | Mar 9, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $38.28M | December 2024 | Mar 9, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$130.3M | December 2025 | Mar 9, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$73.94M | December 2025 | Mar 9, 2026 | 10-K |
| Total assetsAssets | $296.41M | December 2025 | Mar 9, 2026 | 10-K |
| Total liabilitiesLiabilities | $422.65M | December 2025 | Mar 9, 2026 | 10-K |